ERK5 knockdown studies using RNA interference (RNAi) or pharmacological inhibition delay cell cycle progression and decreased proliferation in various cancer types and support the involvement of the MEK5/ERK5 pathway in cancer progression (9). This evidence concerns the gene MAP2K5 and cancer.